Quantitative breast density analysis to predict interval and node-positive cancers in pursuit of improved screening protocols: a case-control study.

Elizabeth S BurnsideLucy M WarrenJonathan MylesLouise S WilkinsonMatthew G WallisMishal PatelRobert A SmithKenneth C YoungNathalie J Massat Stephen W Duffy

Published in: British journal of cancer (2021)

FGV, VBD, VAS and DG discriminate interval cancers from controls, reflecting some masking risk. Only FGV discriminates screen-detected cancers perhaps adding a unique component of breast cancer risk.

Keyphrases

breast cancer risk
lymph node
high throughput
high resolution
mass spectrometry
childhood cancer